Avanza Fonder’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-86,342
Closed -$457K 477
2025
Q1
$457K Buy
86,342
+482
+0.6% +$2.55K 0.02% 390
2024
Q4
$580K Buy
+85,860
New +$580K 0.02% 368